News
Local
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate News
Hot Property
eNewspaper
________________
Subscriptions
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
About Us
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Events
Advertising
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Jobs
CaregiverSD
Community papers
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Games, Puzzles, and Crossword
Crossword
Sudoku
Crossword
Sudoku
Obituaries
Death Notices
Place an obituary
Death Notices
Place an obituary
U-T En Español
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Privacy and Terms
Privacy
Terms
Advertising terms
Privacy
Terms
Advertising terms
Copyright © 2022, The San Diego Union-Tribune |
CA Notice of Collection
|
Do Not Sell My Personal Information
Sections
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate
Obituaries
eNewspaper
Newsletters
Show Search
Search Query
Submit Search
COVID-19
For subscribers
Phenomenal women
Latino life
Crossword
Sudoku
About Us
Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Diego Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Pasithea Therapeutics Corp
(NQ:
KTTA
)
3.820
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 5, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Pasithea Therapeutics Corp
< Previous
1
2
3
4
5
6
7
Next >
12 Health Care Stocks Moving In Thursday's Pre-Market Session
October 03, 2024
Via
Benzinga
Dow Surges Over 250 Points; Accenture Earnings Top Views
September 26, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Thursday's Intraday Session
September 26, 2024
Via
Benzinga
Crude Oil Down Over 2%; US Initial Jobless Claims Fall
September 26, 2024
Via
Benzinga
Exposures
Fossil Fuels
Nasdaq Gains Over 1%; Micron Posts Upbeat Q4 Results
September 26, 2024
Via
Benzinga
Why Is Pasithea Therapeutics Stock Surging On Thursday?
September 26, 2024
Pasithea Therapeutics reports encouraging early Phase 1 data for PAS-004, showing no adverse events or toxicities. The trial highlights safety, tolerability, and preliminary efficacy in patients with...
Via
Benzinga
KTTA Stock Earnings: Pasithea Therapeutics Reported Results for Q2 2024
August 13, 2024
Pasithea Therapeutics just reported results for the second quarter of 2024.
Via
InvestorPlace
KTTA Stock Earnings: Pasithea Therapeutics Reported Results for Q4 2023
June 25, 2024
Pasithea Therapeutics just reported results for the fourth quarter of 2023.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
June 04, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
May 17, 2024
Via
Benzinga
KTTA Stock Earnings: Pasithea Therapeutics Reported Results for Q1 2024
May 15, 2024
Pasithea Therapeutics just reported results for the first quarter of 2024.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
January 26, 2024
Pre-market stock movers are worth checking out on Friday as we get into all of the biggest news affecting shares this morning!
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's Intraday Session
December 25, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 14, 2023
Via
Benzinga
RBLX Stock Alert: Wells Fargo Initiates Roblox Coverage With ‘Overweight’ Rating
December 13, 2023
Roblox stock is rising higher on Wednesday after Wells Fargo initiated coverage of RBLX shares wit a bullish rating and price target.
Via
InvestorPlace
PLTR Stock: Palantir Renews UniCredit Partnership
December 13, 2023
Palantir Technologies stock is slipping on Wednesday even with positive news for PLTR investors in the form of a renewed contract.
Via
InvestorPlace
Why Is ReShape Lifesciences (RSLS) Stock Up 68% Today?
December 13, 2023
ReShape Lifesciences stock is rising with heavy trading of RSLS shares alongside an update from the FDA concerning its weight loss products.
Via
InvestorPlace
Exposures
Product Safety
Why Is Pasithea Therapeutics (KTTA) Stock Down 12% Today?
December 13, 2023
Pasithea Therapeutics stock is falling on Wednesday after shares of KTTA underwent extreme volatility yesterday on study results.
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
December 13, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
December 13, 2023
Pre-market stock movers are a hot topic on Wednesday and we're starting the day with a breakdown of the biggest ones worth watching!
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
December 12, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
December 12, 2023
Checking out the biggest pre-market stock movers for Tuesday is the perfect way to get ready for another busy day of trading!
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
December 11, 2023
Via
Benzinga
Nasdaq Edges Higher; Macy's Shares Jump
December 11, 2023
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 100 points on Monday. The Dow traded up 0.26% to 36,341.44 while the NASDAQ rose 0.12% to 14,421.98. The S&P...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why bluebird bio Shares Are Trading Higher? Here Are Other Stocks Moving In Monday's Mid-Day Session
December 11, 2023
Shares of bluebird bio, Inc. (NASDAQ: BLUE) rose sharply during Monday’s session after the company presented updated data from its gene therapy program in transfusion-dependent beta-thalassemia at the...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
December 11, 2023
Via
Benzinga
Dow Surges 100 Points; Cogent Biosciences Shares Plunge
December 11, 2023
U.S. stocks traded mixed midway through trading, with the Dow Jones index gaining more than 100 points on Monday. The Dow traded up 0.28% to 36,349.22 while the NASDAQ fell 0.36% to 14,352.34. The S&P...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Is Pasithea Therapeutics (KTTA) Stock Up 105% Today?
December 11, 2023
Pasithea Therapeutics stock is climbing higher with heavy trading of KTTA shares alongside results from two preclinical trials.
Via
InvestorPlace
US Stocks Mixed; Cigna Shares Spike Higher
December 11, 2023
U.S. stocks traded mixed this morning, with the Dow Jones index gaining more than 20 points on Monday. Following the market opening Monday, the Dow traded up 0.07% to 36,272.54 while the NASDAQ fell...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Neurology Focused Pasithea Therapeutics Stock Soars Over 150% Today - Here's Why
December 11, 2023
Pasithea Therapeutics Corp (NASDAQ: KTTA) announced preclinical results from two in vivo studies evaluating the antitumor efficacy of PAS-004 in NRAS mutation
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.